Back to search

Article

Explore of potential targets and mechanisms of hesperetin in treating metabolic dysfunction-associated steatosis liver disease via network pharmacology and in vitro experiments

2024-10-08

Abstract excerpt

<title>Abstract</title><p>Metabolic dysfunction-associated steatosic liver disease (MASLD) is a serious public health issue globally; however, there is no specific drug treatment. Hesperetin, a flavonoid extracted from citrus, possesses multiple pharmacological properties. However, limited reports have elucidated the pharmacological targets of and molecular mechanisms underlying hesperetin on lipid metabolism diso...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a2c3042f-30b1-5429-ba8c-714fa1164031
DOI
10.21203/rs.3.rs-5036368/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Explore of potential targets and mechanisms of hesperetin in treating metabolic dysfunction-associated steatosis liver disease via network pharmacology and in vitro experimentsDOI 10.21203/rs.3.rs-5036368/v1
<i>Patolakaturohiniyadi Kashayam</i> , exerts anti-steatotic and anti-obesogenic effects via coordinated regulation of lipid metabolism, inflammation, and incretin signallingSemantic proximity
Integrative multi-omics and multi-trait analysis prioritizes regulatory mechanisms and genes for metabolic dysfunction-associated steatotic liver diseaseSemantic proximity
Mechanism of Sanliangsan Lipid-Lowering in treating hyperlipidemia: insights from network pharmacology and molecular dockingSemantic proximity
Exploring the Mechanism of Danggui Shaoyao San in the treatment of Non-alcoholic Fatty Liver Disease: A Study based on Network Pharmacology and Molecular DockingSemantic proximity
Network Pharmacology Reveals the Multiple Mechanisms of Xiaochaihu Decoction in the Treatment of Non-alcoholic Fatty Liver DiseaseSemantic proximity
Mechanisms of Cynarine for treatment of Non-alcoholic Fatty Liver Disease Based on the Integration of Network Pharmacology, Molecular Docking and Cell ExperimentSemantic proximity
Effects of Gynostemma pentaphyllum on hypolipidemic and the mechanism of network pharmacology and molecular docking in treating hyperlipidaemiaSemantic proximity
Identify Key Active Ingredients and Molecular Mechanisms of Jiangzhi Decoction on Non-alcoholic Fatty Liver Disease by Network Pharmacology AnalysisSemantic proximity
Mechanistic Study of Yang-gan-jie-yu Granules in Treating Postmenopausal Metabolic-Associated Fatty Liver Disease Based on Transcriptomics and Network PharmacologySemantic proximity
Molecular Clustering of Metabolic Dysfunction-Associated Steatotic Liver Disease Based on Transcriptome AnalysisSemantic proximity
Exploring the potential mechanisms of action of Gentiana veitchiorum Hemsl. extract in the treatment of cholestasis using UPLC-MS/MS, systematic network pharmacology, and molecular dockingSemantic proximity
Targeting PKLR and lipogenic enzymes through JNK inhibition to develop a therapeutic strategy for MASLD and MASHSemantic proximity
Select a neighboring publication to make it the new centre.